Erratum to: Human Plasma-Derived, Nanofiltered C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor Deficiency
Biologics in Therapy · 2012
DOI: 10.1007/s13554-012-0004-3 ↗Kurz gefasst
Korrektur in der Zeitschrift Biologics in Therapy, 2012. Verfasst von Henriette Farkas und 1 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Farkas, H., & Varga, L. (2012). Erratum to: Human Plasma-Derived, Nanofiltered C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor Deficiency. Biologics in Therapy. https://doi.org/10.1007/s13554-012-0004-3
Vancouver
Farkas H, Varga L. Erratum to: Human Plasma-Derived, Nanofiltered C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor Deficiency. Biologics in Therapy. 2012. doi:10.1007/s13554-012-0004-3
BibTeX
@article{Farkas2012,
author = {Farkas, Henriette and Varga, Lilian},
title = {Erratum to: Human Plasma-Derived, Nanofiltered C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor Deficiency},
journal = {Biologics in Therapy},
year = {2012},
doi = {10.1007/s13554-012-0004-3}
}
EUVIMED